Bolden Therapeutics
Business Services · Rhode Island, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
225 Dyer St Fl 2, Providence, Rhode Isla...Website
www.boldentherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Bolden Therapeutics
Bolden Therapeutics is a biotechnology company focused on developing first-in-class therapeutics aimed at promoting neurogenesis to improve outcomes for individuals suffering from neurological diseases. Their innovative approach targets specific signaling pathways to enhance the formation of new brain cells, with potential applications in conditions such as Alzheimer's disease, stroke recovery, and treatment-resistant depression. The company is advancing multiple therapeutic modalities, including exon-skipping antisense oligonucleotides, to address cognitive dysfunction and memory impairment. Bolden Therapeutics is committed to transforming the treatment landscape for various CNS illnesses through their groundbreaking research and development efforts.Explore more
Bolden Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bolden Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bolden Therapeutics is spiking on competitors!
Product Launch: Get notified when Bolden Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Bolden Therapeutics
Website visits: Recent activity has been detected on your website
Click to see if Bolden Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Bolden Therapeutics recently announced quarterly report
Check if Bolden Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Bolden Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bolden Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Bolden Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Bolden Therapeutics
Compare insights from companies similar to Bolden Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bolden Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bolden Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bolden Therapeutics.
Bolden Therapeutics financials insights
Gather financial insights about Bolden Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$1.5M
Bolden Therapeutics Tech Stack
A closer look at the technologies used by Bolden Therapeutics
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Funding
Event
Bolden Therapeutics News & Media
BOLDEN THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS
PROVIDENCE, R.I., Jan. 17, 2024 /PRNewswire/ -- Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system illnesses such as Alzheimer's disease, today announced the closing of...Bolden Therapeutics Receives Investment From Lifespan Vision Ventures
Bolden Therapeutics, a Providence, RI-based company developing therapeutics to promote neurogenesis for the potential treatment of central nervous system diseases, received an investment from LifeSpan Vision Ventures. The amount of the deal was not disclosed. The company intends to use the funds to expand operations and its R&D sector. Co-founded by Dr. Justin Fallon and Dr. Ashley Webb and […] The post Bolden Therapeutics Receives Investment From Lifespan Vision Ventures appeared first on FinSMLifespan Vision Ventures invests in Bolden Therapeutics
NORWALK, Conn., Jan. 9, 2024 /PRNewswire/ -- LifeSpan Vision Ventures, an investment firm that specializes in funding longevity biotech breakthroughs, today announced an investment in Bolden Therapeutics, Inc. This biotechnology company is developing first-in-class therapeutics to promote...BOLDEN THERAPEUTICS TO PRESENT AT THE 3RD ANNUAL OLIGONUCLEOTIDES FOR CNS SUMMIT
PROVIDENCE, R.I. and BOSTON, June 7, 2023 /PRNewswire/ -- Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of CNS illnesses, today announced their upcoming presentation at the BIO International...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Bolden Therapeutics
Sign Up For FreeTo access detailed company insights
Bolden Therapeutics is a biotechnology company focused on developing first-in-class therapeutics aimed at promoting neurogenesis to improve outcomes for individuals suffering from neurological diseases. Their innovative approach targets specific signaling pathways to enhance the formation of new brain cells, with potential applications in condition... Read More
